DOGS WITH NON-SEASONAL ATOPIC DERMATITIS TO INVESTIGATE THE EFFECTIVENESS OF TWO DIFFERENT DOSAGES OF A NOVEL IMMUNOTHERAPY DRUG
Principle Investigator
Description
Dogs with Non-Seasonal Atopic Dermatitis to Investigate the Effectiveness of Two Different Dosages of a Novel Immunotherapy Drug
Testing Requirements
– Patients will be required to come in for 10 visits over 24 weeks
– Allergen-Specific IgE Serology (ASIS) testing at Heska
– Patients will be required to stay for the day on the screening visit to be sedated and have IDT allergy testing done
– Injections of the novel immunotherapy drug at the first 4 visits after the screening visit
– Blood work and urinalysis at 2 visits
– Owners have to monitor patient throughout the whole duration of study and to fill out an owner diary daily.
Enrollment Start
10/17/2022
Enrollment Finish
09/12/2023
Eligibility
– Must have NON-SEASONAL Atopic Dermatitis from the House Mite Allergen
– Must have had a proper food trial (6 week minimum). Food allergies must be ruled out or controlled on a hydrolyzed diet.
– Must be on Flea/Tick Preventions for 12 Weeks prior to study and throughout the whole duration of the study.
– Dogs with an active deep pyoderma infection needs to be successfully treated prior to enrollment.
– Dogs will have to be otherwise healthy
– Dogs will have to have clinically unremarkable findings on their complete cell count (CBC), chemistry panel, and urinalysis.
– Patients will need to be taken off certain allergy medications a specific amount of days before IDT allergy testing can be done
Flyer
Contact
Katie Richmond: 919-513-6453 OR cvmclinicalstudies@ncsu.edu
- Categories: